Compare NOC & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NOC | BSX |
|---|---|---|
| Founded | 1939 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.7B | 93.4B |
| IPO Year | 2002 | 2010 |
| Metric | NOC | BSX |
|---|---|---|
| Price | $574.10 | $62.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 22 |
| Target Price | ★ $697.38 | $93.18 |
| AVG Volume (30 Days) | 703.5K | ★ 17.4M |
| Earning Date | 04-21-2026 | 04-22-2026 |
| Dividend Yield | ★ 1.57% | N/A |
| EPS Growth | 2.61 | ★ 55.20 |
| EPS | ★ 6.14 | 1.94 |
| Revenue | ★ $41,954,000,000.00 | $9,076,000,000.00 |
| Revenue This Year | $5.68 | $11.85 |
| Revenue Next Year | $6.20 | $10.16 |
| P/E Ratio | $95.79 | ★ $33.98 |
| Revenue Growth | 2.24 | ★ 12.49 |
| 52 Week Low | $468.29 | $59.52 |
| 52 Week High | $774.00 | $109.50 |
| Indicator | NOC | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 17.99 | 42.87 |
| Support Level | $563.40 | $60.59 |
| Resistance Level | $591.49 | $76.77 |
| Average True Range (ATR) | 16.46 | 1.96 |
| MACD | -10.94 | 0.55 |
| Stochastic Oscillator | 4.75 | 39.92 |
Northrop Grumman is a diversified defense contractor providing aeronautics, defense, and space systems. The company's aerospace segment produces autonomous and piloted aircraft such as Global Hawk drones and the new B-21 bomber, creates the fuselage for the massive F-35 program, and maintains and upgrades numerous other military aircraft. Defense systems makes artillery and missile ammunition and guidance systems, long-range missiles, and missile defense systems. Mission systems creates and integrates a variety of radar, navigation, and communication systems for avionics, weapons control, and countermeasures on a range of platforms from helicopters to destroyers. Space systems produces satellites, sensors, space structures, and rocket motors.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.